Comparison of different preoperative objective nutritional indices for evaluating 30-d mortality and complications after liver transplantation

Table 1 Patient characteristics

Characteristics	Total (n = 162)
Age, yr	53.0 (45.0-57.0)
Male/female	133/29
BMI	23.0 (21.1-25.1)
Hypertension, yes/no	18/144
Diabetes, yes/no	22/140
HBsAg-positive, yes/no	118/44
Operation time (min)	535.0 (440.0-600.0)
Anhepatic phase (min)	58.0 (47.3-66.0)
Donor age, yr	45.0 (36.0-55.0)
Total ischemia time (min)	305.0 (250.5-372.6)
Graft weight (kg)	1.4 (1.3-1.7)
Split LT/whole LT	20/142
Blood loss (mL)	1750.0 (975.0-3925.0)
Intraoperative urine volume (mL)	2650.0 (1600.0-4000.0)
Prealbumin (mg/L)	95.0 (89.7-101.8)
NRI	95.1 (89.7-101.8)
CONUT	6.0 (4.0-6.0)
PNI	42.6 (38.7-46.4)
ALB (g/L)	37.2 (33.6-40.7)
Lymphocyte count (× 109 /mL)	0.9 (0.6-1.5)
Alanine aminotransferase (U/L)	31.0 (19.0-53.3)
Aspartate aminotransferase (U/L)	46.5 (31.0-90.1)
Total bilirubin (μmol/L)	30.8 (15.2-107.2)
Creatinine (umol/L)	71.0 (58.8-85.3)
Preoperative MELD score	12.0 (8.0-22.0)
Total cholesterol (mmol/L)	3.4 (2.2-4.6)
Prothrombin time (s)	16.4 (14.1-20.8)
Platelet (× 109/mL)	67.0 (44.0-150.3)
Death, yes/no	14/148

The data are presented as the median (25^th-75^th percentile) or n. BMI: Body mass index; HBsAg: Hepatitis B surface antigen; CONUT: Control nutritional status; PNI: Prognostic nutritional index; NRI: Nutritional risk index; MELD: Model for end-stage liver disease; LT: Liver transplantation; ALB: Albumin.